Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BalchemBCPC +0.40%81 3-Year EPS without NRI Growth Rate is 8.50% as of Jun. 2026, which is 41% below its 10-year median of 14.30. GuruFocus rates BCPC with a GF Score™ of 81/100 and a GF Value™ of $181.83 (Fairly Valued). The stock has 2 warning signs investors should review. Among 1,254 Chemicals companies, Balchem ranks better than 64.19% on this metric.
During the past 12 months, Balchem's average EPS without NRI Growth Rate was 13.30% per year.
During the past 3 years, the average EPS without NRI Growth Rate was 8.50% per year.
During the past 5 years, the average EPS without NRI Growth Rate was 8.30% per year.
During the past 10 years, the average EPS without NRI Growth Rate was 8.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Balchem was 67.70% per year. The lowest was 0.00% per year. And the median was 14.30% per year.
Balchem (NAS:BCPC) 3-Year EPS without NRI Growth Rate Explanation
EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.
Balchem 3-Year EPS without NRI Growth Rate Related Terms
BCPC vs SXT, PRM, CBT: 3-Year EPS without NRI Growth Rate Comparison
For the Specialty Chemicals subindustry, Balchem's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Balchem 3-Year EPS without NRI Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Balchem's 3-Year EPS without NRI Growth Rate distribution charts can be found below:
* The bar in red indicates where Balchem's 3-Year EPS without NRI Growth Rate falls into.
Balchem 3-Year EPS without NRI Growth Rate Calculation
This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.
What does a 3-Year EPS without NRI Growth Rate of 8.50% mean?
Balchem (BCPC) has a 3-Year EPS without NRI Growth Rate of 8.50% as of Jun. 2026. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Balchem and its competitors. This is 41% below median its historical median of 14.30. According to the industry distribution chart, Balchem ranks #449 out of 1254 companies in the Chemicals industry, placing it in the top 35.8%.
Is Balchem's 3-Year EPS without NRI Growth Rate too high?
Balchem's current 3-Year EPS without NRI Growth Rate of 8.50% is 41% below median its 10-year median of 14.30. Based on the distribution chart, Balchem ranks #449 out of 1254 companies in the Chemicals industry, which is above the industry midpoint. Overall, Balchem has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Balchem's 3-Year EPS without NRI Growth Rate compare to SXT and PRM?
According to the Chemicals industry distribution chart, Balchem ranks #449 out of 1254 companies for 3-Year EPS without NRI Growth Rate. This puts Balchem in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EPS without NRI Growth Rate for a Chemicals company?
A good 3-Year EPS without NRI Growth Rate depends on the Chemicals industry context. However, 3-Year EPS without NRI Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EPS without NRI Growth Rate mean?
A high 3-Year EPS without NRI Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EPS without NRI Growth Rate is the 3-year average growth rate of EPS without NRI. View historical data for Balchem and its competitors. Balchem's current 3-Year EPS without NRI Growth Rate is 8.50%, which is 41% below median its own 10-year median of 14.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Balchem stock overvalued right now?
Based on GuruFocus' analysis, Balchem (BCPC) is currently considered Fairly Valued. The stock's GF Value™ is $181.83, compared to a current price of $179.76 — trading 1.1% below its estimated fair value. The current 3-Year EPS without NRI Growth Rate is 8.50%, which is 41% below median its 10-year median of 14.30. Balchem's overall GF Score™ is 81/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EPS without NRI Growth Rate calculated?
3-Year EPS without NRI Growth Rate is calculated from a company's financial statements. For Balchem (BCPC), the current 3-Year EPS without NRI Growth Rate is 8.50% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Balchem (BCPC) Overvalued in 2026?
Based on GuruFocus' analysis, Balchem stock appears to be undervalued.
The current stock price of $179.76 is trading 1.1% below its estimated GF Value™ of $181.83.
GuruFocus considers Balchem to be Fairly Valued.
Key valuation signals for BCPC:
3-Year EPS without NRI Growth Rate: 8.50% (41% below median its 10-year median of 14.30)
GF Value™: $181.83 vs. price of $179.76 (1.1% below fair value)
No single metric tells the full story. See the BCPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
81GF Score
Get the complete analysis for BCPC
3-Year EPS without NRI Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BCPC has been successfully added to your 
